Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: An update on approaches to management

Keyphrases

• Antineutrophil Cytoplasmic Antibody-associated Vasculitis 100%
• Approaches to Management 100%
• Clinical Trials 50%
• Cyclophosphamide 50%
• Glomerulonephritis 100%
• Infliximab 50%
• Large Vessel Vasculitis 50%
• Medical Specialities 50%
• Methotrexate 50%
• Morbidity Burden 50%
• Mortality Burden 50%
• Multisystem Disease 50%
• Mycophenolate Mofetil 50%
• New Therapies 50%
• Plasma Exchange 50%
• Prednisolone 50%
• Pulmonary Disease 50%
• Rapidly Progressive Glomerulonephritis 50%
• Recent Advances 50%
• Renal Disease 50%
• Renal Vasculitis 50%
• Specific Reference 50%
• Standard of Care 50%
• Vasculitis 50%

Medicine and Dentistry

• Azathioprine 33%
• Clinical Trial 33%
• Cyclophosphamide 33%
• Glomerulonephritis 100%
• Infliximab 33%
• Methotrexate 33%
• Mycophenolate Mofetil 33%
• Nephropathy 33%
• Plasma Exchange 33%
• Prednisolone 33%
• Rapidly Progressive Glomerulonephritis 33%
• Renal Vasculitis 33%
• Silo-Filler's Disease 33%
• Small Vessel Vasculitis 33%
• Systemic Disease 33%
• Vasculitis 100%